[Therapeutically induced arteriogenesis in the brain. A new approach for the prevention of cerebral ischemia with vascular stenosis].
Stroke is the leading cause of disability and a major cause of death in Germany and the western world. Ischemic stroke involves different pathophysiologic mechanisms such as thromboembolic vascular occlusion, cerebral micro- or macroangiopathy, extracranial arterial stenosis, and cardiac embolism. Experimental and clinical studies have shown that arteriogenesis, the adaptive growth of pre-existing collateral arteries, can be therapeutically enhanced in peripheral circulation and the heart. We examined the consequences to time course and hemodynamics of brain arteriogenesis in a chronic hypoperfusion model following systemic administration of the hemopoietic growth factor called granulocyte macrophage colony stimulating factor (GM-CSF). Treatment with GM-CSF led to the growth of intracranial collateral arteries, which improved the cerebral hemodynamic reserve and significantly reduced energy failure when brains were additionally challenged by hypotension. Therapeutically induced arteriogenesis may be of considerable interest for preventing infarction in patients with uncompensated cerebrovascular disease.
Busch
H-J
HJ
Abteilung Kardiologie und Angiologie, Innere Medizin III, Forschergruppe für experimentelle und klinische Arteriogenese, Universitätsklinikum Freiburg. buschj@med1.ukl.uni-freiburg.de
Buschmann
I
I
Schneeloch
E
E
Bode
C
C
Mies
G
G
Hossmann
K-A
KA
D042501:Angiogenic Proteins / Q000008:administration & dosage; D000818:Animals; D001921:Brain / Q000098:blood supply* / Q000187:drug effects / Q000503:physiopathology; D002545:Brain Ischemia / Q000209:etiology / Q000503:physiopathology* / Q000517:prevention & control*; D016893:Carotid Stenosis / Q000150:complications / Q000503:physiopathology* / Q000628:therapy*; D004195:Disease Models, Animal; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage*; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D051381:Rats; D016896:Treatment Outcome
D042501:Angiogenic Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor